Timothy has been a journalist for over 15 years. He has covered business and consumer technology news, and financial analysis.
Biglaw firms are facing significant backlash over their push to recruit first-year law students at an extraordinarily early stage in their legal education. A judge has had their law license suspended after
The North American Income Trust, trading on the London Stock Exchange under the ticker NAIT, has been added to the FTSE 250 Index, marking a significant milestone for the investment trust. Inclusion in the FTSE 250 represents a notable achievement,
Ultragenyx Pharmaceutical (RARE) has earned its first FDA approval in gene therapy, landing an accelerated green light for its treatment targeting glycogen storage disease
Medicare’s remote patient monitoring framework, which launched in 2019, was designed to reimburse providers for tracking patient health data between office visits using home
A bipartisan bill that recently passed the U.S. House of Representatives could fundamentally alter how private-sector employers negotiate first contracts with newly unionised workforces. The Faster Labor Contracts Act would impose mandatory
More
Brandon Etheridge, the former general counsel for the Baltimore Ravens, has joined a major Biglaw firm to help build and lead its growing sports law practice. Etheridge brings substantial insider knowledge to
More
Building a meaningful second income no longer requires a winning performance at Wimbledon or a City bonus cheque. The FTSE 100 has delivered an average annualised total return of around 6.9% since
More
The U.S. Food and Drug Administration has issued a proposed rule that would create a streamlined registration pathway for distributed drug manufacturing establishments operating under a hub-and-spoke model. Under the current regulatory
More
Nevada’s Supreme Court has overturned a key piece of caselaw governing how contingency fee attorneys’ fees are awarded following successful offers of judgment. The ruling, handed down in Clark v. Marin on
More
Legal professionals face mounting pressure to adopt artificial intelligence tools, with negligence claims now a potential consequence of failing to do so in practice. The question of whether a lawyer can be
More
Global equity markets came under pressure as rising geopolitical tensions involving Iran rattled investor sentiment across major US indices on Wednesday. The S&P 500 and Nasdaq Composite both recorded losses as traders
More
Investors searching for income are increasingly turning to FTSE 250 stocks as Cash ISA rates continue to disappoint savers across the United Kingdom. One particular FTSE 250 stock has drawn attention for
More
Hengrui Pharma and Elevar Therapeutics have received a third complete response letter from the FDA for their camrelizumab and rivoceranib combination therapy. The rejection marks more than two years of regulatory setbacks
More
The Supreme Court’s June 25, 2026, decision in Monsanto Company v. Durnell marks the most significant interpretation of FIFRA’s preemption provision since the earlier Bates v. Dow Agrosciences ruling. The landmark ruling
More